- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Erica Mayer on Improving Patient Adherence to Hormonal Therapies
Listening to patient concerns and issues and communicating with them can really help providers keep patients with breast cancer adherent to their hormonal therapies, said Erica Mayer, MD, MPH, assistant professor, medicine, Harvard Medical School.
Listening to patient concerns and issues and communicating with them can really help providers keep patients with breast cancer adherent to their hormonal therapies, said Erica Mayer, MD, MPH, assistant professor, medicine, Harvard Medical School.
Transcript
What tools can physicians employ to improve adherence of hormonal therapies among patients with breast cancer?
I think, you know, a major tool that providers can do to help maintain patients on therapy is communication and listening to how patients are doing assessing their symptoms and acting, and if a patient needs to take a short break, if we need to rotate from one aromatase inhibitor to another, if we need to explore a supportive care medicine, or having a patient try acupuncture exercise—there's a lot of strategies to use.
But I think the most important thing is if a patient is unhappy or uncomfortable or feels like they, they just can't do it, we need to know, and we need to work on that together, rather than not hearing each other and then having somebody stop therapy early.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
